Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.49
1.97 %
$ 918 M
Market Cap
-15.92
P/E
EOLS - STOCK-BASED COMPENSATION
Stock-based Compensation EOLS - Evolus, Inc.
16.5 M
LAST VALUE
31.10%
2 YEAR CAGR
18.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR